Vancouver, BC, Canada – September 7, 2017 – Aspect Biosystems Ltd., a leader in the field of 3D bioprinting and tissue engineering, is proud to be named one of the CIX (Canadian Innovation Exchange) Top 20 Most Innovative Canadian Technology Companies. Aspect is one of just three companies selected from Western Canada.
The CIX Top 20 program is Canada’s largest national showcase of the hottest and most innovative emerging tech companies. Hundreds of applications are submitted each year from across Canada and are judged by a selection committee of technology industry experts and investors from across the country. The CIX Selection Committee evaluates based on several key factors included including product/service offering, depth of management, market opportunity, and business model.
“We are proud to be part of Canada’s impressive ecosystem of innovation and honoured to be recognized on the elite list of CIX Top 20 Most Innovative Technology Companies,” said CEO Tamer Mohamed. “We are taking great strides in making a global and meaningful impact through the development of bioprinted tissues that is paving the way for cutting-edge therapies of the future. We are humbled by this recognition and it is a testament to the great work of our entire team and our commitment to technology innovation and business excellence.”
Aspect CEO Tamer Mohamed will present on Tuesday, October 17, 2017 at the CIX Summit in Toronto, Ontario to share Aspect’s story and unique innovation to a crowd of over 750 investors and peers in the North American technology ecosystem.
See the full Top 20 list here.
ABOUT ASPECT BIOSYSTEMS
Aspect Biosystems Ltd. is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. The company’s proprietary Lab-on-a-Printer™ platform technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to create physiologically and commercially relevant tissues. These tissues are used to advance and accelerate the discovery and development of new drugs and therapies.
ABOUT CANADIAN INNOVATION EXCHANGE (CIX)
CIX is the must attend event for leaders in Canada’s innovation ecosystem. In its 10th year, CIX attracts 750+ technology industry leaders, tech entrepreneurs, investors (VCs, corporates, angels) and advisors from across the Canada and globally. This exclusive event showcases Canada’s most innovative and promising young tech companies and provides the tools for networking, building new relationships and increasing deal flow. CIX facilitates hundreds of new relationships and has fostered hundreds of millions of dollars in transactions. CIX takes place Oct 17-18 2017 at Hilton Toronto. www.cixsummit.comBack to all